ACE-R. Frequently asked questions. We would like to keep all users informed of any changes and updates on the

Size: px
Start display at page:

Download "ACE-R. Frequently asked questions. We would like to keep all users informed of any changes and updates on the"

Transcription

1 ACE-R Frequently asked questions Why do I have to register to download the tests? We would like to keep all users informed of any changes and updates on the tests, normative data, and relevant papers. We are also interested in keeping a register so that we can track how widely used the instrument has become. Why are there 3 different versions (A, B and C)? The versions differ in terms of the name and address recall task. They were designed to avoid learning from one assessment to the next. Some patients may learn the name and address over a couple of years follow-up, making the test invalid. When can I re-assess someone with the ACE-R? Ideally only after 6 months (not earlier), to prevent patients from recalling components for the test. Can I make a dementia diagnosis based on the ACE-R score? No. The ACE-R score should be only part of your clinical assessment, but never used solely for a diagnosis. If your patient has a low score (e.g. below cut-off), you might consider referring them for a thorough neuropsychological assessment, or to a specialist if dementia/cognitive decline has not been raised yet. It is important to remember that low scores can also be due to low 1

2 levels of education, cultural background differences or depression. Although, in our experience, such factors rarely produce a score below 82. Can I rate dementia (e.g. mild, moderate and severe) with an ACE-R score? No. Dementia ratings involve a comprehensive evaluation and should be arrived at after via a thorough clinical assessment involving information from caregivers and family members, and taking into account activities of daily living. We are currently looking at its value in rating dementia severity across different disorders. Can any health professional give the ACE-R? Yes. We recommend you to read the ACE-R guidelines, these frequently asked questions, and to practise administration with a few controls (friend, parent, grandparent, etc) to familiarise yourself with the test. Do I need to pay to use the ACE-R? No. Prof John Hodges holds the ACE-R copyright, but welcomes everyone to use it for clinical and research purposes. Are there normative data for patients above 75? Not at the moment. Our collaborators are currently collecting extended normative data, and we will update all registered users once the norms are established. 2

3 Can I validate the ACE-R in my country? If your language/country is not listed in our website, please contact us to get some background information and authorisation to translate and validate the test. Can I ask for the name of the building where the clinic/rehabilitation ward/outpatient service etc is based, instead of floor? Yes. Sometimes it does not make sense to ask for the floor, so a reasonable adaptation is welcome. Just make sure your team asks the question in the same way, and try to make notes of any changes you might have made for follow-up re-assessments. grfsaz Which scores should I use for the VLOM ratio? VLOM = Verbal fluency (max 14) + Language (max 26)/ Orientation (max 10) + Memory (max 7) Orientation = only two first tasks Memory = only recall of name and address at the end of the test Can I apply the semantic index on the ACE-R? Not directly. The analyses were done using the old ACE, so if you are interested in using the index, you should complement the ACE-R with the questions that make the semantic index to generate the scores you need. 3

4 I use the old ACE; should I change to the revised ACE (ACE-R)? Ideally, yes. After years of use in Cambridge, John Hodges and his team identified many weaknesses on the test, and the revised version was produced and validated. What are the key references on the use of the ACE and ACE-R? ACE Mathuranath PS, Nestor PJ, Berrios GE, Rakowicz W, and Hodges JR. A brief cognitive test battery to differentiate Alzheimer s disease and frontotemporal dementia, Neurology, vol 55, 2000, Dudas RB, Berrios GE, Hodges JR. The Addenbrooke s Cognitive Examination (ACE) in the differential diagnosis of early dementias versus affective disorder, Am J Geriatr Pychiatry, vol 13 (3), March 2005, Galton CJ, Erzinclioglu S, Sahakian BJ, Antoun N, Hodges JR. A comparison of the Addenbroke s Cognitive Examination (ACE), conventional neuropsychologtical assessment, and simple MRI-based medial temporal lobe evaluation in the early diagnosis of Alzheimer s disease, Cog Beh Neurol, vol 18, number 3, September 2005, Bak TH, Rogers TT, Crawford LM, Hearn VC, Mathuranath PS, Hodges JR. Cognitive bedside assessment in atypical parkinsonian syndromes, J Neurol Neurosurg Psychiatry, vol 76, 2005,

5 Mathuranath PS, Cherian JP, Mathew R, George A, Alexander A, Sarma SP. Mini Mental State Examination and the Addenbrooke s Cognitive Examination: effect of education and norms for a multicultural population, Neurology India, vol 55, 2007, Davies RR, Dawson K, Mioshi E, Erzinclioglu S, Hodges JR. Differentiation of semantic dementia and Alzheimer s disease using the Addenbrooke s Cognitive Examination (ACE), International Journal of Geriatric Psychiatry, vol 23, 2008, ACE-R Mioshi E, Dawson K, Mitchell J, Arnold R, Hodges JR. The Addenbrooke s Cognitive Examination Revised (ACE-R): a brief cognitive test for dementia screening, International Journal of Geriatric Psychiatry, vol 21, 2006,

ADDENBROOKE S COGNITIVE EXAMINATION ACE-R

ADDENBROOKE S COGNITIVE EXAMINATION ACE-R ADDENBROOKE S COGNITIVE EXAMINATION ACE-R ACE-R Guide 211 Australian Administration and Scoring Guide - 211 The ACE-R 1 is a brief cognitive test that assesses five cognitive domains, namely attention/orientation,

More information

A review of available translated cognitive assessment tools to assess older people from culturally and linguistically diverse (CALD) backgrounds

A review of available translated cognitive assessment tools to assess older people from culturally and linguistically diverse (CALD) backgrounds A review of available translated cognitive assessment tools to assess older people from culturally and linguistically diverse (CALD) backgrounds F Vrantsidis, Dr D LoGiudice, Dr B Dow V Rayner, Dr S Runci

More information

ADDENBROOKE S COGNITIVE EXAMINATION ACE-R

ADDENBROOKE S COGNITIVE EXAMINATION ACE-R ACE-R Guide 26 ADDENBROOKE S COGNITIVE EXAMINATION ACE-R Administration and Scoring Guide - 26 The ACE-R 1 is a brief cognitive test that assesses five cognitive domains, namely attention/orientation,

More information

Montreal Cognitive Assessment (MoCA) Debbie Froese, B.M.R.-O.T., B.A. Christine Knight, Ph.D.,R.Psych.

Montreal Cognitive Assessment (MoCA) Debbie Froese, B.M.R.-O.T., B.A. Christine Knight, Ph.D.,R.Psych. Montreal Cognitive Assessment (MoCA) Debbie Froese, B.M.R.-O.T., B.A. Christine Knight, Ph.D.,R.Psych. Community Geriatric Mental Health Model of Continuum of Cognition with Aging Normal Mild cognitive

More information

Overview. Neuropsychological Assessment in Stroke. Why a Neuropsychologist. How to make a referral. Referral Questions 11/6/2013

Overview. Neuropsychological Assessment in Stroke. Why a Neuropsychologist. How to make a referral. Referral Questions 11/6/2013 Overview Neuropsychological Assessment in Stroke Brandon Ally, PhD Department of Neurology What is Neuropsychology Stroke Specific Neuropsychology Neuropsychological Domains Case Study What is Neuropsychology?

More information

Alzheimer s disease. The importance of early diagnosis

Alzheimer s disease. The importance of early diagnosis Alzheimer s disease The importance of early diagnosis Key Facts Alzheimer s disease and other dementias 1 Alzheimer's disease is the leading form of dementia and accounts for 50%-75% of all cases. 1 Vascular

More information

Diagnosis and Initial Management of Cognitive Disorders

Diagnosis and Initial Management of Cognitive Disorders Diagnosis and Initial Management of Cognitive Disorders January 29, 2016 Kelly Garrett, PhD Cathleen Obray, MD, MHS Neurosciences Clinical Program Cognitive Care Team None Disclosures Neurosciences Clinical

More information

F rontotemporal dementia (FTD) is the most common

F rontotemporal dementia (FTD) is the most common 920 PAPER Qualitative neuropsychological performance characteristics in frontotemporal dementia and Alzheimer s disease J C Thompson, C L Stopford, J S Snowden, D Neary... J Neurol Neurosurg Psychiatry

More information

The Role of Neuropsychological Testing in Guiding Decision- Making Related to Dementia

The Role of Neuropsychological Testing in Guiding Decision- Making Related to Dementia The Role of Neuropsychological Testing in Guiding Decision- Making Related to Dementia By Scott Knight, Director, SLR Diagnostics & Assessments, a division of Sibley & Associates Inc., and Konstantine

More information

Living well with dementia: A National Dementia Strategy. Accessible Summary. National Dementia Strategy. Putting People First

Living well with dementia: A National Dementia Strategy. Accessible Summary. National Dementia Strategy. Putting People First Living well with dementia: A National Dementia Strategy Accessible Summary National Dementia Strategy Putting People First National Dementia Strategy Accessible Summary This booklet is an accessible version

More information

Neuropsychological assessment clinic

Neuropsychological assessment clinic Neuropsychological assessment clinic Information for families and professionals Ealing child and adolescent mental health service Learning disabilities (CAMHS-LD) August 2014 What is a neuropsychological

More information

Alzheimer s and memory loss

Alzheimer s and memory loss Alzheimer s and memory loss Introduction This introductory leaflet aims to help you understand about memory loss, Alzheimer s disease and other forms of dementia. You can also find out how to get more

More information

2016 Programs & Information

2016 Programs & Information Mayo Alzheimer s Disease Research Clinic Education Center 2016 Programs & Information BROCHURE TITLE FLUSH RIGHT for Persons & Families impacted by Mild Cognitive Impairment Alzheimer s Disease Dementia

More information

Patricia Beldotti, Psy.D. Email: drbeldotti@aol.com Tel: 520-404-7553 Web: www.drbeldotti.com

Patricia Beldotti, Psy.D. Email: drbeldotti@aol.com Tel: 520-404-7553 Web: www.drbeldotti.com Patricia Beldotti, Psy.D. Email: drbeldotti@aol.com Tel: 520-404-7553 Web: www.drbeldotti.com Assessment Costs I understand that assessment needs differ and that these assessments can be costly, especially

More information

Alzheimer s and. memory loss

Alzheimer s and. memory loss Alzheimer s and memory loss This leaflet aims to help you understand about memory loss, Alzheimer s disease and other forms of dementia. You can also find out how to get more information. It s for anyone

More information

Bedside cognitive examination beyond the MMSE. Dr Richard Perry Dept of Neurosciences Imperial College

Bedside cognitive examination beyond the MMSE. Dr Richard Perry Dept of Neurosciences Imperial College Bedside cognitive examination beyond the MMSE Dr Richard Perry Dept of Neurosciences Imperial College Overview Initial observations Cognitive rating scales Assessing cognitive domains Memory Language Visuospatial

More information

1695 N.W. 9th Avenue, Suite 3302H Miami, FL. 33136. Days and Hours: Monday Friday 8:30a.m. 6:00p.m. (305) 355 9028 (JMH, Downtown)

1695 N.W. 9th Avenue, Suite 3302H Miami, FL. 33136. Days and Hours: Monday Friday 8:30a.m. 6:00p.m. (305) 355 9028 (JMH, Downtown) UNIVERSITY OF MIAMI, LEONARD M. MILLER SCHOOL OF MEDICINE CLINICAL NEUROPSYCHOLOGY UHEALTH PSYCHIATRY AT MENTAL HEALTH HOSPITAL CENTER 1695 N.W. 9th Avenue, Suite 3302H Miami, FL. 33136 Days and Hours:

More information

Traumatic brain injury (TBI)

Traumatic brain injury (TBI) Traumatic brain injury (TBI) A topic in the Alzheimer s Association series on understanding dementia. About dementia Dementia is a condition in which a person has significant difficulty with daily functioning

More information

Collaborative Care for Alzheimer s Disease

Collaborative Care for Alzheimer s Disease The Health Care Workforce for Older Americans: Promoting Team Care Institute of Medicine Symposium October 2008 Collaborative Care for Alzheimer s Disease Christopher M. Callahan, MD Cornelius and Yvonne

More information

10 steps to planning for Alzheimer s disease & other dementias A guide for family caregivers

10 steps to planning for Alzheimer s disease & other dementias A guide for family caregivers 10 steps to planning for Alzheimer s disease & other dementias A guide for family caregivers Caring for a person with memory loss or dementia can be challenging. The following ten steps can help caregivers

More information

CRITERIA FOR AD DEMENTIA June 11, 2010

CRITERIA FOR AD DEMENTIA June 11, 2010 CRITERIA F AD DEMENTIA June 11, 2010 Alzheimer s Disease Dementia Workgroup Guy McKhann, Johns Hopkins University (Chair) Bradley Hyman, Massachusetts General Hospital Clifford Jack, Mayo Clinic Rochester

More information

Is the degree of cognitive impairment in patients with Alzheimer s disease related to their capacity to appoint an enduring power of attorney?

Is the degree of cognitive impairment in patients with Alzheimer s disease related to their capacity to appoint an enduring power of attorney? Age and Ageing 2007; 36: 527 531 doi:10.1093/ageing/afm104 The Author 2007. Published by Oxford University Press on behalf of the British Geriatrics Society. All rights reserved. For Permissions, please

More information

No Dementia Stage 2: Very Mild Cognitive Decline

No Dementia Stage 2: Very Mild Cognitive Decline Stages of Dementia Health professionals sometimes discuss dementia in "stages," which refers to how far a person's dementia has progressed. Defining a person's disease stage helps physicians determine

More information

Advanced Clinical Solutions. Serial Assessment Case Studies

Advanced Clinical Solutions. Serial Assessment Case Studies Advanced Clinical Solutions Serial Assessment Case Studies Advanced Clinical Solutions Serial Assessment Case Studies Case Study 1 Client C is a 62-year-old White male who was referred by his family physician

More information

Dementia Causes and Neuropsychological Evaluation of the Older Adult

Dementia Causes and Neuropsychological Evaluation of the Older Adult Dementia Causes and Neuropsychological Evaluation of the Older Adult Laurie N. Culp, Ph.D. Pate and Culp Psychological Assoc. 2440 Lawrenceville Highway Suite 200 Decatur, GA 30033 678-595-0062 lculp@emory.edu

More information

A brief cognitive test battery to differentiate Alzheimer s disease and frontotemporal dementia

A brief cognitive test battery to differentiate Alzheimer s disease and frontotemporal dementia 8. Grigoletto F, Zappalà G, Anderson DW, Lebowitz BD. Norms for the Mini-Mental State Examination in a healthy population. Neurology 1999;53:315 320. 9. O Connor D, Pollitt PA, Brook CP, Reiss BB, Roth

More information

Prediction of the MoCA and the MMSE in Out-patients with the risks of cognitive impairment

Prediction of the MoCA and the MMSE in Out-patients with the risks of cognitive impairment Prediction of the MoCA and the MMSE in Out-patients with the risks of cognitive impairment Teresa Leung Therapist Prince of Wales Hospital 7 th May, 2012 Outline of Presentation Introduction Study Objectives,

More information

Cognitive Testing for Underwriting Life Insurance

Cognitive Testing for Underwriting Life Insurance Cognitive Testing for Underwriting Life Insurance Presentation to the Mortality Working Group of the International Actuarial Association Al Klein April 8, 2011 Cognitive function Agenda What is it? What

More information

TCHP Behavioral Health Psychological/Neuropsychological Testing Child/Adolescent Guidelines

TCHP Behavioral Health Psychological/Neuropsychological Testing Child/Adolescent Guidelines TCHP Behavioral Health Psychological/Neuropsychological Testing Child/Adolescent Guidelines Psychological testing involves the culturally and linguistically competent administration and interpretation

More information

Conducting Geriatric Evaluations: Using Data from WAIS-IV, WMS-IV, and ACSW4W4 Gloria Maccow, Ph.D., Assessment Training Consultant

Conducting Geriatric Evaluations: Using Data from WAIS-IV, WMS-IV, and ACSW4W4 Gloria Maccow, Ph.D., Assessment Training Consultant Conducting Geriatric Evaluations: Using Data from WAIS-IV, WMS-IV, and ACSW4W4 Gloria Maccow, Ph.D. Assessment Training Consultant Objectives Select components of Advanced Clinical Solutions for WAIS-IV

More information

Behavioral Health Psychological/Neuropsychological Testing Guidelines

Behavioral Health Psychological/Neuropsychological Testing Guidelines Behavioral Health Psychological/Neuropsychological Testing Guidelines Psychological testing (procedural code 96101) and Neuropsychological Testing (procedural code 96118) involve the culturally and linguistically

More information

Memory Rehabilitation in Early Dementia. Diana Golvers Clinical Psychologist Central Dementia Service

Memory Rehabilitation in Early Dementia. Diana Golvers Clinical Psychologist Central Dementia Service Memory Rehabilitation in Early Dementia Diana Golvers Clinical Psychologist Central Dementia Service Loss of Memory in AD Memory impairment earliest manifestation of AD and other dementias Major impact

More information

Psychological Society of Ireland Division of Neuropsychology

Psychological Society of Ireland Division of Neuropsychology Psychological Society of Ireland Division of Neuropsychology Dr. Brian Waldron Senior Clinical Neuropsychologist Chair- PSI Division of Neuropsychology 27th February 2016 Neurological / Neuropsychological

More information

Objectives. Evaluation of Memory Loss. Cognitive Impairment. Clinical Questions. Medicare Wellness Visit

Objectives. Evaluation of Memory Loss. Cognitive Impairment. Clinical Questions. Medicare Wellness Visit Evaluation of Memory Loss and Mild Cognitive Impairment Skotti Church, MD Geriatrics Grand Rounds 4/3/2014 Objectives 1. Describe recommendations and tools for evaluation of cognitive impairment 2. Define

More information

DEMENTIA SEVERITY RATING SCALE (DSRS)

DEMENTIA SEVERITY RATING SCALE (DSRS) PARTICIPANT S NAME: DATE: PERSON COMPLETING FORM: Please circle the most appropriate answer. Do you live with the participant? No Yes How much contact do you have with the participant? Less than 1 day

More information

Steps to getting a diagnosis: Finding out if it s Alzheimer s Disease.

Steps to getting a diagnosis: Finding out if it s Alzheimer s Disease. Steps to getting a diagnosis: Finding out if it s Alzheimer s Disease. Memory loss and changes in mood and behavior are some signs that you or a family member may have Alzheimer s disease. If you have

More information

WMS III to WMS IV: Rationale for Change

WMS III to WMS IV: Rationale for Change Pearson Clinical Assessment 19500 Bulverde Rd San Antonio, TX, 28759 Telephone: 800 627 7271 www.pearsonassessments.com WMS III to WMS IV: Rationale for Change Since the publication of the Wechsler Memory

More information

Cognitive Assessment and Mini Mental Status Exam for Nurses. Sarah Krieger-Frost RN MN/ Heather Rea MSW RSW Seniors Mental Health Capital District

Cognitive Assessment and Mini Mental Status Exam for Nurses. Sarah Krieger-Frost RN MN/ Heather Rea MSW RSW Seniors Mental Health Capital District Cognitive Assessment and Mini Mental Status Exam for Nurses Sarah Krieger-Frost RN MN/ Heather Rea MSW RSW Seniors Mental Health Capital District Objectives An understanding of what makes up a cognitive

More information

Dementia 1. A Neuropsychological Review of Dementia. Lisa K. Samuel

Dementia 1. A Neuropsychological Review of Dementia. Lisa K. Samuel Dementia 1 A Neuropsychological Review of Dementia Lisa K. Samuel Dementia 2 Abstract Dementia is a neurological disorder resulting in the loss of multiple brain functions and has been increasingly diagnosed

More information

Top US Gerontology Centers and Programs

Top US Gerontology Centers and Programs Page 1 of 5 Top US Gerontology Centers and Programs Top 7 Gerontology Programs With Great Public Resources By Sara Rattigan, Caring.com contributing writer From:http://www.caring.com/articles/top-us-gerontology-centers-and-programs

More information

Malattia di Alzheimer: L importanza della Diagnosi e del Trattamento Precoce: la Collaborazione MMG-Specialista

Malattia di Alzheimer: L importanza della Diagnosi e del Trattamento Precoce: la Collaborazione MMG-Specialista 55 Congresso Nazionale SIG Firenze Auditorium Palazzo dei Congressi 2 Dicembre 2010 Invecchiamento e Longevità: più Geni o più Ambiente Malattia di Alzheimer: L importanza della Diagnosi e del Trattamento

More information

Primary Care Update January 28 & 29, 2016 Alzheimer s Disease and Mild Cognitive Impairment

Primary Care Update January 28 & 29, 2016 Alzheimer s Disease and Mild Cognitive Impairment Primary Care Update January 28 & 29, 2016 Alzheimer s Disease and Mild Cognitive Impairment Kinga Szigeti, MD Associate Professor UBMD Neurology UB Department of Neurology Questions How do we differentiate

More information

Curriculum Vitae. Board Certification: American Board of Professional Psychology Clinical Neuropsychology and Pediatric Neuropsychology

Curriculum Vitae. Board Certification: American Board of Professional Psychology Clinical Neuropsychology and Pediatric Neuropsychology Place of Birth: Washington, DC Curriculum Vitae Karen Spangenberg Postal, Ph.D., ABPP-CN 166 North Main Street Suite 3B Andover, MA 01810 (978) 475-2025 E-mail: karenpostal@comcast.net Board Certification:

More information

Neuropsychological Testing

Neuropsychological Testing Last Review Date: March 17, 2015 Number: MG.MM.ME.18dC2 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth

More information

Staging and Treatment of Dementia

Staging and Treatment of Dementia Staging and Treatment of Dementia Ami Hall DO 10/25/14 1 Objectives What are the two most common types of dementias seen in a primary care office How are they staged What treatments are available Definition

More information

Billing, Coding and Reimbursement Guide

Billing, Coding and Reimbursement Guide Billing, Coding and Reimbursement Guide Revised April 2014 Disclaimer: The information in this document has been compiled for your convenience and is not intended to provide specific coding or legal advice.

More information

Article from: Product Matters! June 2012 Issue 83

Article from: Product Matters! June 2012 Issue 83 Article from: Product Matters! June 2012 Issue 83 Alzheimer s Disease as a Critical Illness Trigger: Does it Really Make Sense? By Stephen Rowley and Cyriac Kottoor Gen Re has reinsured Critical Illness

More information

A-level PSYCHOLOGY (7182/1)

A-level PSYCHOLOGY (7182/1) SPECIMEN MATERIAL A-level PSYCHOLOGY (7182/1) Paper 1 Introductory Topics in Psychology 2017 Morning Time allowed: 2 hours Materials For this paper you may have: a calculator. Instructions Use black ink

More information

Social Security Disability Insurance and young onset dementia: A guide for employers and employees

Social Security Disability Insurance and young onset dementia: A guide for employers and employees Social Security Disability Insurance and young onset dementia: A guide for employers and employees What is Social Security Disability Insurance? Social Security Disability Insurance (SSDI) is a payroll

More information

Update on Treatment of the Dementias

Update on Treatment of the Dementias Update on Treatment of the Dementias Mark Pippenger, MD Behavioral Neurology Associate Clinical Professor of Neurology University of Arkansas for Medical Sciences Disclosures I will be discussing off-label

More information

How To Know If You Can Test For A Mental Health Test On A Medicare Card

How To Know If You Can Test For A Mental Health Test On A Medicare Card Billing, Coding and Reimbursement Guide Updated January 2007 Disclaimer: The information in this document has been compiled for your convenience and is not intended to provide specific coding or legal

More information

Community Network for Dementia and Critical Path in Japan

Community Network for Dementia and Critical Path in Japan Research and Reviews Community Network for Dementia and Critical Path in Japan JMAJ 54(5): 305 309, 2011 Satoshi ORIMO* 1 Abstract In Setagaya City of Tokyo, regional hospitals and medical associations

More information

Cholinesterase inhibitors and memantine use for Alzheimer s disease TOPIC REVIEW

Cholinesterase inhibitors and memantine use for Alzheimer s disease TOPIC REVIEW Cholinesterase inhibitors and memantine use for Alzheimer s disease TOPIC REVIEW Diagnosis of Dementia : DSM-IV criteria Loss of memory and one or more other cognitive abilities Aphasia Apraxia Agnosia

More information

Dementia: Delivering the Diagnosis

Dementia: Delivering the Diagnosis Dementia: Delivering the Diagnosis Daniel D. Christensen, M.D. Clinical Professor of Psychiatry Clinical Professor of Neurology Adjunct Professor of Pharmacology University of Utah Diagnosing Dementia

More information

CART Community Assessment of Risk Tool

CART Community Assessment of Risk Tool CART Community Assessment of Risk Tool 0 3-0 7. 2 0 1 2 D E M E N T I A L E A R N I N G E V E N T M U L L I N G A R PA R K H O T E L T U E S D AY 3 R D J U LY 2 0 1 2 D R R Ó N Á N O C A O I M H P R O

More information

Brief Intervention for Substance Abuse among Rural Elderly

Brief Intervention for Substance Abuse among Rural Elderly Brief Intervention for Substance Abuse among Rural Elderly Shivanand Kattimani 1, Sonali Sakar, K C Premarajan, Gautam Roy Department of Preventive and Social Medicine & 1 Department of Psychiatry, Dhanvantari

More information

Age Associated Cognitive Decline and Mild Cognitive Impairment (MCI)

Age Associated Cognitive Decline and Mild Cognitive Impairment (MCI) Age Associated Cognitive Decline and Mild Cognitive Impairment (MCI) Mike R. Schoenberg, PhD, ABPP-CN Diplomate, American Board of Clinical Neuropsychology Licensed Psychologist Departments of Psychiatry

More information

Y OUR GUIDE TO. Neuropsychological Assessment

Y OUR GUIDE TO. Neuropsychological Assessment Y OUR GUIDE TO Neuropsychological Assessment Your Guide to Neuropsychological Assessment is part of a series of information products about brain injury produced by a joint committee of brain injury organisations

More information

Alzheimer's: The Latest Assessment and Treatment Strategies

Alzheimer's: The Latest Assessment and Treatment Strategies Questions from chapter 1 Alzheimer's: The Latest Assessment and Treatment Strategies 1) What is a loss of cognitive and intellectual powers without changes in consciousness. a) dementia b) delusions c)

More information

Changes affecting concentration,

Changes affecting concentration, When Should An Older Adult Be Referred to Neuropsychology? provide a systematic, evidence-based and comprehensive approach to assessing an individual s cognitive and emotional functioning, and can complement

More information

Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)

Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) Supplement 1 This supplement provides * subtest means and SDs for the normal standardization sample, * comments on general issues

More information

TESTING GUIDELINES PerformCare: HealthChoices. Guidelines for Psychological Testing

TESTING GUIDELINES PerformCare: HealthChoices. Guidelines for Psychological Testing TESTING GUIDELINES PerformCare: HealthChoices Guidelines for Psychological Testing Testing of personality characteristics, symptom levels, intellectual level or functional capacity is sometimes medically

More information

Objectives. Aging and Forgetfulness Define Dementia Types of Dementia Treatment

Objectives. Aging and Forgetfulness Define Dementia Types of Dementia Treatment Dementia David Lam, MD, FRCPC, Psychiatry Assistant Clinical Professor Department of Psychiatry and Behavioural Neurosciences McMaster University Hamilton, Ontario Objectives Aging and Forgetfulness Define

More information

Evaluation of Cognitive Status and Dementia in OCTO Twin

Evaluation of Cognitive Status and Dementia in OCTO Twin Evaluation of Cognitive Status and Dementia in OCTO Twin Boo Johansson The memory and cognitive battery encompassed the following questions and tests: 1. Orientation to own person (Full Name, Year of birth,

More information

Alzheimer s disease. What is Alzheimer s disease?

Alzheimer s disease. What is Alzheimer s disease? Alzheimer s disease What is Alzheimer s disease? What we know about dementia and Alzheimer s disease Alzheimer s disease is the most common of a large group of disorders known as dementias. It is an irreversible

More information

How to WOW! Your Guests

How to WOW! Your Guests Tools Technology Skills How to WOW! Your Guests Training Workbook Copyright 2005 Choice Hotels International WOW! Page 3 4 WOW! Page WOW! Page 5 What is WOW! Service? What is WOW!? and service! WOW! separates

More information

The Relationship Between Anhedonia & Low Mood

The Relationship Between Anhedonia & Low Mood Rebecca M. Floyd, Ph.D., Kimberly Lewis, Ph.D., Eliot Lopez, M.S., Thomas Toomey, B.A., Kena Arnold, B.A., and Lara Stepleman, Ph.D. The lifetime prevalence of depression in patients with MS is approximately

More information

Johns Hopkins Memory & Alzheimer s Treatment Center

Johns Hopkins Memory & Alzheimer s Treatment Center Memory is The Memory Center has not only provided great care to my husband, but also has helped me learn to care for myself while caring for him. - Sylvia Mackey Have you forgotten someone s name you should

More information

Communication Strategies for Primary Progressive Aphasia & FTD s:

Communication Strategies for Primary Progressive Aphasia & FTD s: Communication Strategies for Primary Progressive Aphasia & FTD s: Maura English Silverman, MS, CCC/SLP Triangle Aphasia Project FTD Conference July 12, 2011 summary Individuals with cognitive and communication

More information

Introducing the WAIS IV. Copyright 2008 Pearson Education, inc. or its affiliates. All rights reserved.

Introducing the WAIS IV. Copyright 2008 Pearson Education, inc. or its affiliates. All rights reserved. Introducing the WAIS IV Overview Introduction Revision Goals Test Structure Normative / Validity / Clinical Information Wechsler s View of Intelligence "The global capacity of a person to act purposefully,

More information

Psychological and Neuropsychological Testing

Psychological and Neuropsychological Testing Psychological and Neuropsychological Testing I. Policy University Health Alliance (UHA) will reimburse for Psychological and Neuropsychological Testing (PT/NPT) when it is determined to be medically necessary

More information

ALZHEIMER S DISEASE CAREGIVING ADVISORY GROUP

ALZHEIMER S DISEASE CAREGIVING ADVISORY GROUP - 1 - ALZHEIMER S DISEASE CAREGIVING ADVISORY GROUP Convened by the National Alliance for Caregiving Through generous funding of Wyeth & Élan Alliance April 8, 2009 - 2 - Represented Organizations Alzheimer

More information

Appropriate Use of CPT Coding in Treatment of Persons with Memory Impairment

Appropriate Use of CPT Coding in Treatment of Persons with Memory Impairment Appropriate Use of CPT Coding in Treatment of Persons with Memory Impairment Cameron J. Camp, Ph.D. Director of Research and Development Center for Applied Research in Dementia Cameron@CEN4ard.com www.cen4ard.com

More information

COURSE APPROVAL GUIDELINES APS COLLEGE OF CLINICAL NEUROPSYCHOLOGISTS

COURSE APPROVAL GUIDELINES APS COLLEGE OF CLINICAL NEUROPSYCHOLOGISTS Page 1 COURSE APPROVAL GUIDELINES APS COLLEGE OF CLINICAL NEUROPSYCHOLOGISTS Updated October 2000 Page 2 1. General Introduction and Principles Clinical neuropsychology is a division of psychology concerned

More information

Early Signs of Dementia. Purpose of Session: Early Signs of Dementia. Occasional Early Changes in Memory or Thinking Function

Early Signs of Dementia. Purpose of Session: Early Signs of Dementia. Occasional Early Changes in Memory or Thinking Function Early Signs of Dementia Prepared by: Leilani Doty, PhD, Director, University of Florida Cognitive & Memory Disorder Clinics (MDC), Box 100236, McKnight Brain Institute, Gainesville, FL 32610-0236, Office

More information

Geriatric Assessment Tools. Dr. Hermes

Geriatric Assessment Tools. Dr. Hermes Geriatric Assessment Tools Dr. Hermes Geriatric Assessment Learning Objectives 1. Identify factors contributing to the need for specialized assessment of the frail older adult 2. Discuss the benefits of

More information

Dr. Patrick Healey is a board certified full time geriatrician. Undergraduate degree from Wabash College, a Masters degree in Teaching and a Medical

Dr. Patrick Healey is a board certified full time geriatrician. Undergraduate degree from Wabash College, a Masters degree in Teaching and a Medical Dr. Patrick Healey is a board certified full time geriatrician. Undergraduate degree from Wabash College, a Masters degree in Teaching and a Medical degree from Indiana University. He completed an Internal

More information

Cognitive Interventions for Mild Cognitive Impairment

Cognitive Interventions for Mild Cognitive Impairment Cognitive Interventions for Mild Cognitive Impairment Kelly Murphy, PhD Neuropsychology & Cognitive Health, Baycrest Health Sciences Psychology Department, University of Toronto Aging & Speech Communication:

More information

Frequently Asked Questions

Frequently Asked Questions Frequently Asked Questions Business Office: 598 Airport Boulevard Suite 1400 Morrisville NC 27560 Contact: support@cognitrax.com Phone: 888.750.6941 Fax: 888.650.6795 www.cognitrax.com Diseases of the

More information

Memantine (Ebixa) Drug treatment for Alzheimer s disease

Memantine (Ebixa) Drug treatment for Alzheimer s disease IS 20 October 2011 Information sheet Memantine (Ebixa) Drug treatment for Alzheimer s disease Introduction... 1 How does Ebixa work?... 1 Who might benefit?... 2 What effect might Ebixa have?... 2 How

More information

Primary Endpoints in Alzheimer s Dementia

Primary Endpoints in Alzheimer s Dementia Primary Endpoints in Alzheimer s Dementia Dr. Karl Broich Federal Institute for Drugs and Medical Devices (BfArM) Kurt-Georg-Kiesinger-Allee 38, D-53175 Bonn Germany Critique on Regulatory Decisions in

More information

take care of yourself How to recognize and manage caregiver stress

take care of yourself How to recognize and manage caregiver stress take care of yourself How to recognize and manage caregiver stress 10 ways to manage stress and be a healthier caregiver Are you so overwhelmed by taking care of someone else that you have neglected your

More information

Meeting the Needs of Aging Persons. Aging in Individuals with a

Meeting the Needs of Aging Persons. Aging in Individuals with a Meeting the Needs of Aging Persons with Developmental Disabilities Cross Network Collaboration for Florida Aging in Individuals with a Developmental Disability Module 3 Based on ADRC training developed

More information

The diagnosis of dementia for people living in care homes. Frequently Asked Questions by GPs

The diagnosis of dementia for people living in care homes. Frequently Asked Questions by GPs The diagnosis of dementia for people living in care homes Frequently Asked Questions by GPs A discussion document jointly prepared by Maggie Keeble, GP with special interest in palliative care and older

More information

Curriculum Vitae. Psychology Atlanta, GA Psy.D., 2011 Concentration: Clinical Neuropsychology

Curriculum Vitae. Psychology Atlanta, GA Psy.D., 2011 Concentration: Clinical Neuropsychology Curriculum Vitae Education: September, 2006-November, 2011 September, 2006-August, 2008 September, 2001-May, 2005 Georgia School of Professional Psychology Atlanta, GA Psy.D., 2011 Concentration: Clinical

More information

PARTNERING WITH YOUR DOCTOR:

PARTNERING WITH YOUR DOCTOR: PARTNERING WITH YOUR DOCTOR: A Guide for Persons with Memory Problems and Their Care Partners Alzheimer s Association Table of Contents PARTNERING WITH YOUR DOCTOR: When is Memory Loss a Problem? 2 What

More information

Montreal Cognitive Assessment (MoCA) as Screening tool for cognitive impairment in mtbi.

Montreal Cognitive Assessment (MoCA) as Screening tool for cognitive impairment in mtbi. Montreal Cognitive Assessment (MoCA) as Screening tool for cognitive impairment in mtbi. Suresh Kumar, M.D. AUTHOR Director of: Neurology & Headaches Center Inc. Neurocognitve &TBI Rehabilitation Center

More information

Tune Up Your Memory. Overview of course. A Few Statistics 2/3/2015

Tune Up Your Memory. Overview of course. A Few Statistics 2/3/2015 Tune Up Your Memory Michelle Swantek Certified Geriatric Wellness Instructor MorningStar Senior Living Boise Overview of course How Memory Works How the Brain Works Use It or Lose It Nutrition and Exercise

More information

MEMORY LOSS: WHAT IS NORMAL?

MEMORY LOSS: WHAT IS NORMAL? MEMORY LOSS: WHAT IS NORMAL? When I was first unable to remember things like the names of my friend s children or an appointment, I felt scared. Robert, 73 years old lawyer Everyone forgets things. Who

More information

Metacognition. Complete the Metacognitive Awareness Inventory for a quick assessment to:

Metacognition. Complete the Metacognitive Awareness Inventory for a quick assessment to: Metacognition Metacognition is essential to successful learning because it enables individuals to better manage their cognitive skills and to determine weaknesses that can be corrected by constructing

More information

DEMENTIA SCREENING. James E. Galvin, MD, MPH Alzheimer Disease Research Center Washington University School of Medicine

DEMENTIA SCREENING. James E. Galvin, MD, MPH Alzheimer Disease Research Center Washington University School of Medicine DEMENTIA SCREENING James E. Galvin, MD, MPH Alzheimer Disease Research Center Washington University School of Medicine Disclosures and Acknowledgements This study was funded by the Longer Life Foundation

More information

Frequently Asked Questions About Our Preventative Care Offering

Frequently Asked Questions About Our Preventative Care Offering Frequently Asked Questions About Our Preventative Care Offering Q: What is different in the Preventative Care service that I would not get in the Traditional service? Time, access, and focus on healthy

More information

F rontotemporal dementia is the term currently favoured to

F rontotemporal dementia is the term currently favoured to 371 PAPER Changes in appetite, food preference, and eating habits in frontotemporal dementia and Alzheimer s disease M Ikeda, J Brown, A J Holland, R Fukuhara, J R Hodges... See Editorial Commentary, page

More information

Slide 1. Prior to the memory team there were a number of different pathways for the diagnosis and treatment of those suffering from dementia

Slide 1. Prior to the memory team there were a number of different pathways for the diagnosis and treatment of those suffering from dementia 1 Talk for High Performance Conference: The Counties Manukau Memory Team Slide 1 Where did the Memory Team come from? Sue Thompson, Northern Regional Dementia Advisor for the Ministry of Health and Dr

More information

PLANNING FUTURE CARE. Wishes & Preferences for My Future Care. This Plan belongs to:

PLANNING FUTURE CARE. Wishes & Preferences for My Future Care. This Plan belongs to: PLANNING FUTURE CARE Wishes & Preferences for My Future Care This Plan belongs to: Planning Your Future Care What is this Plan for? This Care Plan is your opportunity to think ahead and write down what

More information

Failing to Get the Gist: Reduced False Recognition of Semantic Associates in Semantic Dementia

Failing to Get the Gist: Reduced False Recognition of Semantic Associates in Semantic Dementia Neuropsychology Copyright 2005 by the American Psychological Association 2005, Vol. 19, No. 3, 353 361 0894-4105/05/$12.00 DOI: 10.1037/0894-4105.19.3.353 Failing to Get the Gist: Reduced False Recognition

More information

WHODAS 2.0 World Health Organization Disability Assessment Schedule 2.0 36-item version, self-administered

WHODAS 2.0 World Health Organization Disability Assessment Schedule 2.0 36-item version, self-administered The APA is offering a number of emerging measures for further research and clinical evaluation. These patient assessment measures were developed to be administered at the initial patient interview and

More information

TEACHER IDENTITY AND DIALOGUE: A COMMENT ON VAN RIJSWIJK, AKKERMAN & KOSTER. Willem Wardekker VU University Amsterdam, The Netherlands

TEACHER IDENTITY AND DIALOGUE: A COMMENT ON VAN RIJSWIJK, AKKERMAN & KOSTER. Willem Wardekker VU University Amsterdam, The Netherlands International Journal for Dialogical Science Spring 2013. Vol. 7, No. 1, 61-65 Copyright 2013 by Willem Wardekker TEACHER IDENTITY AND DIALOGUE: A COMMENT ON VAN RIJSWIJK, AKKERMAN & KOSTER Willem Wardekker

More information

The Financial Impact of Alzheimer s on Family Caregivers: 2014

The Financial Impact of Alzheimer s on Family Caregivers: 2014 The Financial Impact of Alzheimer s on Family Caregivers: 2014 To raise awareness of the impact of Alzheimer s disease and other forms of dementia on families during Alzheimer s Awareness Month and Family

More information

Assessment, Case Conceptualization, Diagnosis, and Treatment Planning Overview

Assessment, Case Conceptualization, Diagnosis, and Treatment Planning Overview Assessment, Case Conceptualization, Diagnosis, and Treatment Planning Overview The abilities to gather and interpret information, apply counseling and developmental theories, understand diagnostic frameworks,

More information